Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01078350
Recruitment Status : Completed
First Posted : March 2, 2010
Last Update Posted : November 20, 2017
Sponsor:
Information provided by (Responsible Party):
Stanford University

Brief Summary:
This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.

Condition or disease Intervention/treatment
Lymphoma Hodgkin Disease Procedure: tumor tissue aspiration Procedure: phlebotomy

Detailed Description:
The purpose of this study is to provide a mechanism to obtain tissue specimens to be used for experimental studies before the exact histologic diagnosis is known.

Layout table for study information
Study Type : Observational
Actual Enrollment : 93 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
Actual Study Start Date : May 2004
Actual Primary Completion Date : December 4, 2015
Actual Study Completion Date : December 4, 2015

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Further analysis [ Time Frame: at collection time ]

Biospecimen Retention:   Samples With DNA
tissues sample


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study.
Criteria

Inclusion Criteria:

  • Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study.

Exclusion Criteria:

  • None.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01078350


Locations
Layout table for location information
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Layout table for investigator information
Principal Investigator: Dr. Neyssa Marina Stanford University
Layout table for additonal information
Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01078350    
Other Study ID Numbers: BANKPEDSTS0001
80003
SU-11052007-794 ( Other Identifier: Stanford )
First Posted: March 2, 2010    Key Record Dates
Last Update Posted: November 20, 2017
Last Verified: November 2017
Keywords provided by Stanford University:
Lymphoma
Hodgkin Disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Hodgkin Disease
Lymphoma
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases